Patric Stenberg, Founder of Gesynta Pharma

Patric Stenberg is the founder of Gesynta Pharma. Gesynta Pharma has raised $67M in total funding. Latest round: Series B. Based in Stockholm, Sweden.

About Patric Stenberg

Patric Stenberg is the CEO of Gesynta Pharma, a company developing vipoglanstat, a novel non-hormonal drug candidate for the treatment of endometriosis. Gesynta Pharma recently secured SEK 304 million in a Series B financing round to advance vipoglanstat towards being Phase III-ready, with a focus on a European Phase II clinical trial.

Patric Stenberg at a glance

More founders in Stockholm, Sweden (44)

Browse related founder lists (6)

Full founder directory · Investor directory · Company funding database · Fundraising library